ERTUGLIFLOZIN PIDOLATE vs ERYTHROMYCIN LACTOBIONATE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
ERTUGLIFLOZIN PIDOLATE vs ERYTHROMYCIN LACTOBIONATE: Safety Overview
| Metric | ERTUGLIFLOZIN PIDOLATE | ERYTHROMYCIN LACTOBIONATE |
|---|---|---|
| Total FAERS Reports | 681 | 106 |
| Deaths Reported | 4 | 9 |
| Death Rate | 0.6% | 8.5% |
| Hospitalizations | 128 | 24 |
| Average Patient Age | 57.0 yrs | 54.7 yrs |
| % Female Patients | 56.1% | 60.0% |
| FDA Approval Date | N/A | Approved Prior to Jan 1, 1982 |
| Manufacturer | Merck Sharp & Dohme LLC | Gland Pharma Limited |
| Route | ORAL | INTRAVENOUS |
| Marketing Status | N/A | Discontinued |